Focusing on Women's Cancers
BioSpectrum Asia|BioSpectrum Asia Dec 2023
Breast and cervical cancer are pressing threats to women and health systems in the Asia Pacific APAC) region. A new multisectoral collaboration and a powerful analysis of six countries’ breast and cervical cancer prevention and care capacity are generating momentum to save lives and contribute to a global health movement.
Focusing on Women's Cancers

Asia accounts for 45 per cent of global breast cancer cases and 58 per cent of global cervical cancer deaths. New cervical cancer diagnoses in the region are projected to rise by 18.9 per cent by 2030, with deaths increasing by almost 25 per cent, while breast cancer diagnoses in the region are projected to rise by 20.9 per cent and deaths by 27.8 per cent in that same period. These rates are tracking higher than anticipated global rates of increase, sounding the alarm for policy makers, funders and civil society partners alike to act, as behind these alarming statistics lie the disheartening individual stories of women and their families.

In addition to grappling with the physical challenges of cancer, women also confront significant emotional, psychological, and financial strains. Because these diseases also carry the risk of stigma, they place a burden on women who are unable or unwilling to share their health challenges with others. Beyond these psychosocial impacts, women who must leave the workplace due to illness, or as caretakers, must contend with financial constraints resulting from lost income and compounded by catastrophic out of pocket payments on health care. Such scenarios can often pull families into cycles of poverty and impact future generations.

Investing in women’s cancer 

Denne historien er fra BioSpectrum Asia Dec 2023-utgaven av BioSpectrum Asia.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra BioSpectrum Asia Dec 2023-utgaven av BioSpectrum Asia.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA BIOSPECTRUM ASIASe alt
Prof. Christian Wolfrum to join NTU as Deputy President and Provost
BioSpectrum Asia

Prof. Christian Wolfrum to join NTU as Deputy President and Provost

Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Japan suggests addition of PVA into drugs for strong antitumour activity
BioSpectrum Asia

Japan suggests addition of PVA into drugs for strong antitumour activity

Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.

time-read
1 min  |
BioSpectrum Asia Feb 2025
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
BioSpectrum Asia

"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"

2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.

time-read
5 mins  |
BioSpectrum Asia Feb 2025
BeiGene names Giancarlo Benelli as Head of Europe biz
BioSpectrum Asia

BeiGene names Giancarlo Benelli as Head of Europe biz

BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Korea develops innovative injectable adhesive hydrogel for bone regeneration
BioSpectrum Asia

Korea develops innovative injectable adhesive hydrogel for bone regeneration

A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.

time-read
1 min  |
BioSpectrum Asia Feb 2025
When Clinical Trials Suffer From 'Complicated' Interactions
BioSpectrum Asia

When Clinical Trials Suffer From 'Complicated' Interactions

Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.

time-read
5 mins  |
BioSpectrum Asia Feb 2025
Dr Krishna M Ella receives prestigious INSA India fellowship
BioSpectrum Asia

Dr Krishna M Ella receives prestigious INSA India fellowship

Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Bruker launches infrared imaging microscope for pharma and life science research
BioSpectrum Asia

Bruker launches infrared imaging microscope for pharma and life science research

US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
BioSpectrum Asia

Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities

Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
BioSpectrum Asia

Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers

US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.

time-read
1 min  |
BioSpectrum Asia Feb 2025